Skip to content

Does the Application of Cold Decreases the Pain Associated in the Pose of a Patch of Capsaicine at High Concentration on the Carrier Patients of Localized Neuropathic Pains ? - DIDOCAP

Does the Application of Cold Decreases the Pain Associated in the Pose of a Patch of Capsaicine at High Concentration on the Carrier Patients of Localized Neuropathic Pains ? - DIDOCAP

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02869867
Acronym
DIDOCAP
Enrollment
100
Registered
2016-08-17
Start date
2017-03-02
Completion date
2020-12-04
Last updated
2025-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Localized Neuropathic Pain

Brief summary

Nursing study, prospective, randomized, two-center open-label. Patients will be randomized into two groups during their first laying Qutenza®: * Patients receiving the laying of Qutenza® without refrigerated cushion * Patients receiving the laying of Qutenza® associated with a refrigerated cushion The objective of the study is to evaluate the effectiveness of the application of cold to the reduction of pain (burning) after one hour of patch installation high concentration capsaicin (Qutenza®) in patients localized neuropathic pain.

Interventions

OTHERrefrigerated cushion

refrigerated cushion

Sponsors

Centre Hospitalier Departemental Vendee
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Major * Do not opposing the participation in the study * Monitoring in the case of localized neuropathic pain * Diagnostic with neuropathic pain score ≥ 4 * Neuropathic pain conventional treatment failure of first-line * Front advantage of laying a first patch Qutenza® * With ability to understand the proposed study

Exclusion criteria

* Patch Installation on the feet, face, mucous membranes * Eutectic mixture of local anesthetics (EMLA) Pose premedication * Having Already received prior to the installation of a patch of Qutenza® * Allergy to components Qutenza® * Known and poorly stabilized hypertension * Known cryoglobulinaemia * Pregnant or lactating women * Patient enjoying a measure of legal protection (guardianship, guardianship ...) * Private Patient freedom * No affiliation to a social security scheme. * Refusal to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Visual Analogue Pain Scale (Burning Pain)after 1 hour of installation of Qutenza patchBurning pain will be estimated by the patient using a non-graduated 10 cm line, presented horizontally to the patient with the extreme position of the vertical border on the left (0mm) representing the absence of perceived pain and the extreme position on the right (10 cm), the perception of the maximum pain that the patient can imagine. The information obtained is measured and translated into a score between 0 and 10. The patient will be asked: How would you rate the intensity of pain caused by Qutenza patch application?

Countries

France

Participant flow

Participants by arm

ArmCount
Qutenza® Without Refrigerated Cushion
Qutenza® without refrigerated cushion
49
Qutenza® With Refrigerated Cushion
Qutenza® with refrigerated cushion refrigerated cushion: refrigerated cushion
50
Total99

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up55
Overall StudyProtocol Violation10

Baseline characteristics

CharacteristicQutenza® Without Refrigerated CushionQutenza® With Refrigerated CushionTotal
Age, Continuous51 years
STANDARD_DEVIATION 12
49 years
STANDARD_DEVIATION 14
50 years
STANDARD_DEVIATION 13
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
34 Participants40 Participants74 Participants
Sex: Female, Male
Male
15 Participants10 Participants25 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 00 / 0
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Visual Analogue Pain Scale (Burning Pain)

Burning pain will be estimated by the patient using a non-graduated 10 cm line, presented horizontally to the patient with the extreme position of the vertical border on the left (0mm) representing the absence of perceived pain and the extreme position on the right (10 cm), the perception of the maximum pain that the patient can imagine. The information obtained is measured and translated into a score between 0 and 10. The patient will be asked: How would you rate the intensity of pain caused by Qutenza patch application?

Time frame: after 1 hour of installation of Qutenza patch

Population: Intent to treat Population (all participants who received a Qutenza patch)

ArmMeasureValue (LEAST_SQUARES_MEAN)
Qutenza® without refrigerated cushionVisual Analogue Pain Scale (Burning Pain)6.99 units on a scale
Qutenza® with refrigerated cushionVisual Analogue Pain Scale (Burning Pain)3.78 units on a scale
p-value: <0.00195% CI: [2.09, 4.31]Mixed Models Analysis

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026